O365 Email | M.D./Employees

Now enrolling for new breast cancer study

Research is a vital step in the fight against breast cancer. The majority of breast cancers are hormone-receptor positive, which means the cancer cells grow in response to hormones. The purpose of this study is to evaluate whether the study drug combined with hormonal therapy has better outcomes than hormonal therapy alone. The Herald Bulletin released its annual Best of Madison County awards today, and Community Hospital Anderson was honored with several awards.

Community Hospital Anderson was named "Best Company to work for" this year. As one of the largest employers in Madison County, Community Hospital Anderson is committed to keeping jobs here in our community and caring for all within our reach, both our patients and employees.

Holly Renz, RN was named "Best Nurse" for the fourth time. Holly has touched countless lives in her 39 years as an employee at Community Hospital Anderson. Since 1998, she has served as the coordinator of Community's Sexual Assault Treatment Center. As a sexual assault nurse examiner, she is a tireless advocate for victims of sexual abuse.

Dr. Traci Anderson, family physician was honored as the "Best Doctor" for the second year in a row. Dr. Anderson's patients love her unique approach to medicine. She focuses on wellness, while providing personalized, family-oriented care.

Community Hospital Anderson is always seeking qualified applicants for our open positions. If you are interested in becoming a part of the team at Community Hospital Anderson, please click here. We also have Volunteer opportunities.

If you have been diagnosed with breast cancer, you may qualify to participate in the study. The length of the study is approximately 36 weeks. The study drug will be provided at no cost, and reasonable travel expenses may be reimbursed. Your decision to participate in the study will not affect the medical care you receive from your doctor or oncologist.

This study is enrolling now. To see if you qualify or ask questions about the study, please call us at 765-298-2080 between 8 a.m. and 4:30 p.m. After hours calls can be made to 765-203-1301. You may also email us at clinicaltrials@ecommunity.com.